Old Web
English
Sign In
Acemap
>
authorDetail
>
Catherine Visconte
Catherine Visconte
Medicine
Thrombosis
Antithrombotic
Thrombin
Pharmacology
5
Papers
46
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis
2004
Journal of Thrombosis and Haemostasis
Catherine Visconte
M. Sainte-Marie
Janine Lorrain
L. Millet
Steve O’Connor
Paul Schaeffer
Jean-Marc Herbert
Show All
Source
Cite
Save
Citations (4)
Thrombolysis induced by streptokinase or recombinant plasminogen activator (rt-PA) is improved by SSR182289A, a direct orally active thrombin inhibitor, in rabbit models of thrombosis
2003
Journal of Thrombosis and Haemostasis
Catherine Visconte
Janine Lorrain
M. Sainte-Marie
L. Millet
Steve O’Connor
Paul Schaeffer
Jean-Marc Herbert
Show All
Source
Cite
Save
Citations (0)
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor
2003
Journal of Pharmacology and Experimental Therapeutics
Janine Lorrain
L. Millet
Irène Lechaire
Sylvette Lochot
Patrice Ferrari
Catherine Visconte
M. Sainte-Marie
Catherine Lunven
Christopher Berry
Paul Schaeffer
Jean-Marc Herbert
Steve O’Connor
Show All
Source
Cite
Save
Citations (24)
Activity of a Sub-cutaneously Administered Novel Mixed Micellar Formulation of Argatroban in Rat and Rabbit Models of Venous Thrombosis
2000
Thrombosis and Haemostasis
Christopher Berry
Catherine Visconte
Catherine Lecoffre
Sylvette Lochot
Denise Girard
Show All
Source
Cite
Save
Citations (6)
Antithrombotic activity of argatroban in experimental thrombosis in the rabbit
1996
Seminars in Thrombosis and Hemostasis
Christopher Berry
Denise Girard
Christine Girardot
Sylvette Lochot
Catherine Lunven
Catherine Visconte
Show All
Source
Cite
Save
Citations (12)
1